logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
Leukemia cover

Leukemia

IF13.4
Papers11254
Citations30658
Journal Papers 12025
Publication Date
delete
MAIA frailty subgroup analysis: long-term follow-up with daratumumab plus lenalidomide/dexamethasone in transplant-ineligible newly diagnosed myeloma
deleteLeukemia
IF13.4
delete2026-10-06
delete0
deleteOAAI
deleteThierry Facon; Gordon Cook; Saad Z. Usmani; Cyrille Hulin; Shaji Kumar; Cyrille Touzeau; Nizar J. Bahlis; Supratik Basu; Hartmut Goldschmidt; Hang Quach; Mohamad Mohty; Christopher P. Venner; Katja Weisel; Noopur Raje; Salomon Manier; Mai Ngo; Marjohn Armoon; Kasey Bolyard; Fredrik Borgsten; Robin Carson; Sonja Zweegman
deleteShare
deleteSave
KT-253, a highly potent and selective MDM2 protein degrader, eliminates malignant myelofibrosis stem/progenitor cells
deleteLeukemia
IF13.4
delete2026-10-06
delete0
deleteOAAI
deleteMin Lu; Lijuan Xia; Yogesh Chutake; Joyoti Dey; Ronald Hoffman
deleteShare
deleteSave
Sensitivity to ATR–CHK1 pathway inhibition in MDS/AML is enhanced by SRSF2 mutations and reduced by RUNX1 loss
deleteLeukemia
IF13.4
delete2026-10-06
delete0
deleteOAAI
deleteSamuli Eldfors; Sumit Rai; Vineet Sharma; Tareq Hossan; Claudia Cabrera Pastrana; Amy Bertino; Angelique Gilbert; Sridhar Nonavinkere Srivatsan; Kimmo Porkka; Matthew J. Walter; Timothy A. Graubert
deleteShare
deleteSave
Methodological considerations on TP53 variant classification for standardized reporting and interpretation
deleteLeukemia
IF13.4
delete2026-10-06
delete0
PREAI
deleteKok-Siong Poon
deleteShare
deleteSave
Chronic myeloid leukemia in a global context: confirmatory findings and novel discoveries from a refined Japanese Cohort
deleteLeukemia
IF13.4
delete2026-10-06
delete0
PREAI
deleteMai Fujita; Hiroshi Ureshino; Shinya Kimura
deleteShare
deleteSave
Venetoclax-based therapy versus hypomethylating agents alone in unfit patients with newly diagnosed acute myeloid leukemia: a real-world study from the PETHEMA registry
deleteLeukemia
IF13.4
delete2026-10-06
delete0
deleteOAAI
deleteGaspar Aspas Requena; Eliana Aguiar; Joana Brioso; Rosa Ayala; Josefina Serrano López; Jorge Labrador Gómez; Eduardo Rodríguez-Arbolí; Mar Tormo; Teresa Bernal del Castillo; Olga Arce Fernández; Francisco Ibáñez Alís; Manuel Pérez Encinas; Carlos Rodríguez-Medina; Ágata Almela Gallego; Olga Salamero; José Luis López Lorenzo; Claudia Lucía Sossa Melo; María José Mela Osorio; Juan Miguel Bergua Burgues; Susana Vives; Aitor Abuín; María Dolores Madrigal; Cristina Gil; Alberto Giménez Conca; Marta Valero Núñez; José Mário Mariz; María-Ángeles Foncillas; Silvina Palmer; Marcela Espinoza; Bernardo Javier González González; María Carmen García Garay; Lara María Gómez García; Daniel García Belmonte; Ana Alfonso Piérola; Diana Marcela Cuervo Lozada; Carlos Varón; Ana Lisa Basquiera; Miguel López; María Lourdes Amador Barciela; María Solé Rodríguez; María Marta Rivas; Sandra Casal Marini; Alicia Roldán Pérez; María-Belén Vidriales; Raimundo García Boyero; Isabel Recio; María Luz Amigo; Kenny Gálvez; Pilar Lloret Madrid; Pau Montesinos
deleteShare
deleteSave
Measurable residual disease-guided, fixed-duration, potentially definitive therapy for standard risk newly diagnosed multiple myeloma
deleteLeukemia
IF13.4
delete2026-10-06
delete0
PREAI
deleteBhagirathbhai R. Dholaria; Eva Medvedova; Gayathri Ravi; Binod Dhakal; Natalie S. Callander; Kelly N. Godby; Susan Bal; Timothy Schmidt; Rebecca W. Silbermann; Luciano J. Costa
deleteShare
deleteSave
Recombinant hematopoietic growth factors in acute myeloid leukemia
deleteLeukemia
IF13.4
delete2026-10-05
delete0
PREAI
deleteMargery Gang; Robert Peter Gale; Roland B. Walter
deleteShare
deleteSave
Inhibition of ROR1 signaling with zilovertamab plus ibrutinib in chronic lymphocytic leukemia: safety, mechanistic insights, and an exploratory signal in del(17p) disease
deleteLeukemia
IF13.4
delete2026-10-02
delete0
deleteOAAI
deleteMichael Y. Choi; Emanuela M. Ghia; Tanya Siddiqi; Jacqueline C. Barrientos; Joseph Tuscano; Jean L. Koff; Salim Yazji; Lori A. Leslie; Iris Isufi; Nicole Lamanna; Alec Goldenberg; Gina Chung; Suki Subbiah; James M. Robinson; Susan O’Neill; Catriona H. M. Jamieson; James B. Breitmeyer; William G. Wierda; Thomas J. Kipps
deleteShare
deleteSave
First-line ibrutinib-venetoclax in chronic lymphocytic leukemia: GLOW 67-month results and grade 3/4 adverse event-free progression-free survival
deleteLeukemia
IF13.4
delete2026-10-02
delete0
deleteOAAI
deleteCarsten U. Niemann; Talha Munir; Carolyn Owen; George Follows; José-Ángel Hernández-Rivas; Ohad Benjamini; Ann Janssens; Mark-David Levin; Tadeusz Robak; Martin Simkovic; Sergey Voloshin; Vladimir Vorobyev; Loic Ysebaert; Natasha Schuier; Kurt Baeten; Nguyet Tran; Bennett Levitan; Claire Kavanagh; Arnon P. Kater
deleteShare
deleteSave
Alterations in 3D-DNA architecture drive unique leukemic profiles in IDH1- and DNMT3A-mutant acute myeloid leukemia
deleteLeukemia
IF13.4
delete2026-10-01
delete0
deleteOAAI
deleteSophie Steinhäuser; Varun K. A. Sreenivasan; David Baden; Miriam Denker; Thomas Beder; Kathrin Richter; Theodor Hutter; Britta Steer; Verónica Yumiceba; Kristin Schultz; Alina Maria Hartmann; Nadine Wolgast; Simone Lipinski; Lorenz Bastian; Sonja Bendig; Monika Brüggemann; Lars Fransecky; Martin Neumann; Patricia Silva; Christoph Röllig; Malte Spielmann; Claudia Dorothea Baldus
deleteShare
deleteSave
ROR1 upregulation after CD19-CAR T-cell relapse in mantle cell lymphoma identifies a targetable vulnerability for ROR1-directed bispecific modalities
deleteLeukemia
IF13.4
delete2026-10-01
delete0
deleteOAAI
deleteYixin Yao; Fangfang Yan; Xiaolin Li; Yijing Li; Yue Fei; Joseph McIntosh; Wei Wang; Heng-Huan Lee; Yang Liu; Michael Wang
deleteShare
deleteSave
Two cases of an imatinib-sensitive PRKG2::PDGFRA-positive chronic myeloid neoplasm with basophilia
deleteLeukemia
IF13.4
delete2026-09-28
delete0
deleteOAAI
deleteJohannes Lübke; Olaposi Yomade; Manja Meggendorfer; Jan-Hendrik Kozik; Marietta Truger; Wencke Walter; Stephan Hutter; Uwe Martens; Martina Rudelius; Nicole Naumann; Alice Fabarius; Matthew Salmon; Carl Crodel; Jenny Rinke; Hans-Peter Horny; Florian H. Heidel; Jan Hinrich Bräsen; Hans-H. Kreipe; Georgia Metzgeroth; Wolf-Karsten Hofmann; Nicholas C. P. Cross; Torsten Haferlach; Juliana Schwaab; Andreas Hochhaus; Andreas Reiter
deleteShare
deleteSave
PIM1 in myeloproliferative neoplasms: potential pathogenic and therapeutic implications
deleteLeukemia
IF13.4
delete2026-09-28
delete0
deleteOAAI
deleteAvik Dutta; Lilian Varricchio; Ronald Hoffman; Golam Mohi
deleteShare
deleteSave
Exploiting an epigenetic resistance mechanism to PI3-kinase inhibition in leukemic stem cells
deleteLeukemia
IF13.4
delete2026-09-28
delete0
deleteOAAI
deleteShira G. Glushakow-Smith; Imit Kaur; Simone Sidoli; Shayda Hemmati; Ellen Angeles; Taneisha Sinclair; Samarpana Chakraborty; Aaliyah Battle; Kristina Ames; Swathi-Rao Narayanagari; Rotila Hyka; Mark Soto; Melissa Tracy; Jayaram Vankudoth; Seiya Kitamura; Linde A. Miles; Ulrich Steidl; Aditi Shastri; Amit Verma; Kira Gritsman
deleteShare
deleteSave
Clinical and molecular characteristics of clonal monocytosis with and without cytopenia(s)
deleteLeukemia
IF13.4
delete2026-09-28
delete0
PREAI
deleteTariq Kewan; Hadil Zureigat; Pradeep Pankaj; Rong He; Dragan Jevremovic; Patricia Greipp; Antoine N. Saliba; Aasiya Matin; Mehrdad Hefazi Torghabeh; Naseema Gangat; William Hogan; Hassan Alkhateeb; Cecilia Arana Yi; James Foran; Mark Litzow; Mithun Vinod Shah; Kebede Begna; Badar Talha; Yael Kusne; Abhishek A. Mangaonkar; Aref Al-Kali; Kaaren Reichard; Mrinal M. Patnaik
deleteShare
deleteSave
Selective dependency of CALR-mutant myeloproliferative neoplasms on TYK2 signaling
deleteLeukemia
IF13.4
delete2026-09-24
delete0
deleteOAAI
deleteMilena Kalmer; Chiara Wirths; Rebecca Lemanzyk; Alessia Piergentili; Mia Mönnig; Chunxiao Zhou; Bärbel Junge; Jonas Goßen; Siddharth Gupta; Laura Schulz; Anna Spitzer; Stefan Tillmann; Kim Kricheldorf; Joelle Schifflers; Kristina Pannen; Angela Galauner; Jacob Piehler; Christian Pecquet; Marcelo A. S. de Toledo; Stefan N. Constantinescu; Giulia Rossetti; Steffen Koschmieder; Nicolas Chatain
deleteShare
deleteSave
Aberrant expression of MERTK activates BCR via CD79a in CLL cells: alternative therapeutic strategy for relapsed/refractory CLL
deleteLeukemia
IF13.4
delete2026-09-23
delete0
PREAI
deleteMariana T. Mendez; Tapojyoti Sanyal; Murali K. Mamidi; Stacey M. Fernandes; Sara K. Vesely; Marek Mraz; Jennifer R. Brown; Jennifer Holter-Chakrabarty; Asish K. Ghosh
deleteShare
deleteSave
C3- and C5-deficient murine cells exhibit severe mitochondrial defects, indicating a pivotal, novel role of innate immunity in regulating hematopoiesis at the electron transfer chain level
deleteLeukemia
IF13.4
delete2026-09-22
delete0
deleteOAAI
deleteMichalina Kazek; Damian Wojdalski; Adrian Konopko; Patrycja Kieszek; Agnieszka Lukomska; Kannathasan Thetchinamoorthy; Hanna Nieznańska; Magdalena Świadek; Emilia Waraksa-Zasada; Janina Ratajczak; Magdalena Kucia; Mariusz. Z. Ratajczak
deleteShare
deleteSave
Incidentally detected vertebral fractures and risk of myeloma: a prospective cohort study of 9059 CT-scanned Danish general population individuals
deleteLeukemia
IF13.4
delete2026-09-18
delete0
deleteOAAI
deleteRasmus Rønnemoes; Anne Rudbeck Juhl; Shoaib Afzal; Stig Egil Bojesen; Børge Grønne Nordestgaard; Michael Huy Cuong Pham; Klaus Fuglsang Kofoed; Jørgen Tobias Kühl; Andreas Fuchs Larsen; Per Ejlstrup Sigvardsen; Thomas S. Kristensen; Jesper Petersen; Andreas Glenthøj; Jens Helby
deleteShare
deleteSave